Intestinal epithelial-specific PTEN inactivation results in tumor formation
Do-Sun Byun1, Naseem Ahmed, Shannon Nasser
1Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, New York, USA.
Abstract:
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a negative regulator of phosphatidylinositol 3-kinase (PI3K) signaling that is frequently inactivated in colorectal cancer through mutation, loss of heterozygosity, or epigenetic mechanisms. The aim of this study was to determine the effect of intestinal-specific PTEN inactivation on intestinal epithelial homeostasis and tumorigenesis. PTEN was deleted specifically in the intestinal epithelium, by crossing PTEN(Lox/Lox) mice with villin(Cre) mice. PTEN was robustly expressed in the intestinal epithelium and maximally in the differentiated cell compartment. Targeted inactivation of PTEN in the intestinal epithelium of PTEN(Lox/Lox)/villin(Cre) mice was confirmed by genotyping, immunohistochemistry, and qPCR. While intestinal-specific PTEN deletion did not have a major effect on cell fate determination or proliferation in the small intestine, it did increase phosphorylated (p) protein kinase B (AKT) expression in the intestinal epithelium, and 19% of animals developed small intestinal adenomas and adenocarcinomas at 12 mo of age. These tumors demonstrated pAKT and nuclear β-catenin staining, indicating simultaneous activation of the PI3K/AKT and Wnt signaling pathways. These findings demonstrate that, while PTEN inactivation alone has a minimal effect on intestinal homeostasis, it can facilitate tumor promotion upon deregulation of β-catenin/TCF signaling, further establishing PTEN as a bona fide tumor suppressor gene in intestinal cancer.
Insights
Inactivating phosphatase and tensin homolog (PTEN) in the intestine minimally affects homeostasis but promotes small intestinal tumors by activating PI3K/AKT and Wnt pathways, confirming PTEN
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Phosphatase and tensin homolog (PTEN) is a key tumor suppressor, negatively regulating phosphatidylinositol 3-kinase (PI3K) signaling.
- PTEN inactivation is common in colorectal cancer via mutation, loss of heterozygosity, or epigenetic silencing.
- Understanding PTEN's role in intestinal tumorigenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the impact of intestinal-specific PTEN deletion on intestinal epithelial homeostasis.
- To determine the role of PTEN inactivation in the development of intestinal tumors.
- To elucidate the signaling pathways involved in PTEN-deficient intestinal tumorigenesis.
Main Methods:
- Generation of PTEN(Lox/Lox)/villin(Cre) mice for conditional intestinal epithelial PTEN deletion.
- Confirmation of PTEN inactivation using genotyping, immunohistochemistry, and qPCR.
- Analysis of intestinal homeostasis, cell fate, proliferation, and tumor development.
Main Results:
- Intestinal PTEN deletion increased phosphorylated AKT (pAKT) expression in the intestinal epithelium.
- 19% of PTEN-deficient mice developed small intestinal adenomas and adenocarcinomas by 12 months.
- Tumors exhibited co-activation of PI3K/AKT and Wnt signaling pathways (pAKT and nuclear β-catenin staining).
Conclusions:
- Intestinal PTEN inactivation alone has a limited effect on normal intestinal homeostasis.
- PTEN inactivation cooperates with Wnt pathway deregulation to promote intestinal tumor formation.
- These findings reinforce PTEN's role as a critical tumor suppressor in the intestine.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...


